Abbott | ABT - Trade Debtors


Abbott reported $10.57B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Abbott USD 10.57B 171M Dec/2025
Agilent USD 1.5B 23M Mar/2026
AtriCure USD 71.31M 4.66M Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Bio-Rad Laboratories USD 460.6M 4.1M Dec/2025
Boston Scientific USD 2.93B 98M Dec/2025
Cooper Companies USD 809.2M 2.1M Mar/2026
Danaher USD 4.76B 845M Mar/2026
Dexcom USD 1.09B 182.1M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Globus Medical USD 735.44M 8.23M Mar/2026
Insulet USD 544.7M 27.8M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
Intuitive Surgical USD 1.6B 68.3M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Masimo USD 288.9M 103M Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Merit Medical Systems USD 227M 3.39M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Smith & Nephew USD 1.48B 85M Dec/2025
Solventum Corp USD 1.35B 163M Mar/2026
Stryker USD 3.57B 468M Mar/2026
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 365.53M 19.94M Mar/2026
Terumo JPY 217.57B 2.28B Mar/2026
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026